focus -WSS

focus

author：fashion 2025-08-12 08:30:15 - browse：116

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Novo Nordisk obesity pill bests Wegovy in early trial

Wikipedia

WSS

CDC marks new Covid

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

For pregnant people, addiction treatment shouldn't mean a call to child protective services

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

RSV shot was 90% effective at preventing hospitalizations in kids

FTC loses bid to block Novant's North Carolina hospital merger

focus

focus

focus

Jerome Adams on the need for new antivirals for Covid

STAT wants to know your pick for a great summer read or listen

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The drug industry has found itself all alone in Washington

Peter Hotez and the public health issue of online harassment

Sutter Health’s antitrust win overturned by appeals court

Medical leaders decry Supreme Court decision on affirmative action

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Novavax promises a turnaround & Lilly roils the obesity market

Illumina board agrees to spin off Grail, as divestment plans proceed

focus

Change Healthcare cyberattack prompts Medicare loan program

A deep dive into Applied Therapeutics’ data, and questions on Cassava

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Congress needs to close a vaccine

Eli Lilly’s Zepbound improved liver scarring in mid

Change Healthcare cyberattack prompts Medicare loan program

Wikipedia

focus

Wikipedia

hotspot